We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$12M
(-11%)
Cap. Flow
-$9.67M
Cap. Flow
% of AUM
-9.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
3
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$2.58M |
| 2 |
Quanterix
QTRX
|
+$2.45M |
| 3 |
Personalis
PSNL
|
+$202K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Natera
NTRA
|
+$7.44M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$4.43M |
| 3 |
TEM
Tempus AI
TEM
|
+$3.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Blue Water Life Science Advisors held 9 positions worth $101M, down 11% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blue Water Life Science Advisors withdrew a net $9.67M in Q1 2025, closing 2 positions and reducing 1 holding. Its most notable exit was Exact Sciences, an estimated $4.43M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Blue Water Life Science Advisors added an estimated $2.58M to CareDx.
- Blue Water Life Science Advisors added most to CareDx in Q1 2025, an estimated $2.58M increase.
- Blue Water Life Science Advisors's biggest Q1 2025 reduction was Natera, cutting an estimated $7.44M.
- Blue Water Life Science Advisors fully exited Exact Sciences in Q1 2025, selling an estimated $4.43M.
- Blue Water Life Science Advisors's ten largest holdings make up 100% of its $101M portfolio in Q1 2025.
- Blue Water Life Science Advisors opened 0 new positions and closed 2 in Q1 2025.
- Blue Water Life Science Advisors's portfolio value fell 11% quarter-over-quarter to $101M.
Based on Blue Water Life Science Advisors's 13F filing for Q1 2025, filed 15 May 2025.